Access the full text.
Sign up today, get DeepDyve free for 14 days.
Hogyu Han, P. Weinreb, P. Lansbury (1995)
The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?Chemistry & biology, 2 3
C. Goldsbury, S. Wirtz, Shirley Müller, S. Sunderji, Peter Wicki, U. Aebi, P. Frey (2000)
Studies on the in Vitro Assembly of Aβ 1–40: Implications for the Search for Aβ Fibril Formation InhibitorsJournal of Structural Biology, 130
A. Kajava, U. Aebi, A. Steven (2005)
The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin.Journal of molecular biology, 348 2
Kei-ichi Yamaguchi, H. Katou, M. Hoshino, K. Hasegawa, H. Naiki, Y. Goto (2004)
Core and heterogeneity of beta2-microglobulin amyloid fibrils as revealed by H/D exchange.Journal of molecular biology, 338 3
J. Goers, V. Uversky, A. Fink (2003)
Polycation‐induced oligomerization and accelerated fibrillation of human α‐synuclein in vitroProtein Science, 12
(2002)
Protein Sci. 11:2362–69
Luc Bousset, V. Redeker, P. Decottignies, S. Dubois, P. Maréchal, R. Melki (2004)
Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.Biochemistry, 43 17
G. Marcon, Georgia Plakoutsi, C. Canale, A. Relini, N. Taddei, C. Dobson, G. Ramponi, F. Chiti (2005)
Amyloid formation from HypF-N under conditions in which the protein is initially in its native state.Journal of molecular biology, 347 2
D. Walsh, Bertrand Tseng, R. Rydel, M. Podlisny, D. Selkoe (2000)
The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.Biochemistry, 39 35
R. Tycko (2003)
Insights into the amyloid folding problem from solid-state NMR.Biochemistry, 42 11
C. Goldsbury, G. Cooper, K. Goldie, S. Müller, E. Saafi, W. Gruijters, Martin Misur, A. Engel, U. Aebi, J. Kistler (1997)
Polymorphic fibrillar assembly of human amylin.Journal of structural biology, 119 1
G. Merlini, V. Bellotti (2003)
Molecular mechanisms of amyloidosis.The New England journal of medicine, 349 6
M. Fändrich, V. Forge, Katrin Buder, Marlis Kittler, C. Dobson, S. Diekmann (2003)
Myoglobin forms amyloid fibrils by association of unfolded polypeptide segmentsProceedings of the National Academy of Sciences of the United States of America, 100
L. Lue, Y. Kuo, A. Roher, L. Brachova, Yong Shen, L. Sue, T. Beach, J. Kurth, R. Rydel, J. Rogers (1999)
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s DiseaseAmerican Journal of Pathology, 155
E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk, L. Mucke (2000)
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.Science, 287 5456
Ani Der-Sarkissian, C. Jao, Jeannie Chen, R. Langen (2003)
Structural Organization of α-Synuclein Fibrils Studied by Site-directed Spin Labeling*Journal of Biological Chemistry, 278
Matthew Dedmon, K. Lindorff-Larsen, J. Christodoulou, M. Vendruscolo, C. Dobson (2005)
Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations.Journal of the American Chemical Society, 127 2
Walraj Gosal, I. Morten, E. Hewitt, D. Smith, N. Thomson, S. Radford (2005)
Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid.Journal of molecular biology, 351 4
C. Wurth, N. Guimard, M. Hecht (2002)
Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis.Journal of molecular biology, 319 5
Georgia Plakoutsi, Francesco Bemporad, Martino Calamai, N. Taddei, C. Dobson, F. Chiti (2005)
Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates.Journal of molecular biology, 351 4
I. Kheterpal, Angela Williams, Charles Murphy, Brian Bledsoe, Ronald Wetzel (2001)
Structural features of the Abeta amyloid fibril elucidated by limited proteolysis.Biochemistry, 40 39
R. Bader, R. Bamford, J. Zurdo, B. Luisi, C. Dobson (2006)
Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation.Journal of molecular biology, 356 1
S. Petty, T. Adalsteinsson, S. Decatur (2005)
Correlations among morphology, beta-sheet stability, and molecular structure in prion peptide aggregates.Biochemistry, 44 12
C. Sőti, Csaba Pál, Balázs Papp, P. Csermely (2005)
Molecular chaperones as regulatory elements of cellular networks.Current opinion in cell biology, 17 2
O. Makin, L. Serpell, L. Serpell (2004)
Structural characterisation of islet amyloid polypeptide fibrils.Journal of molecular biology, 335 5
C. Guela, Chuang‐Kuo Wu, D. Saroff, A. Lorenzo, M. Yuan, B. Yankner (1998)
Aging renders the brain vulnerable to amyloid β-protein neurotoxicityNature Medicine, 4
P. Hammarström, Xin Jiang, A. Hurshman, E. Powers, J. Kelly (2002)
Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversityProceedings of the National Academy of Sciences of the United States of America, 99
Jun Wang, D. Dickson, J. Trojanowski, V. Lee (1999)
The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic AgingExperimental Neurology, 158
M. Ramírez-Alvarado, Jane Merkel, Lynne Regan (2000)
A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro.Proceedings of the National Academy of Sciences of the United States of America, 97 16
M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddei, G. Ramponi, C. Dobson, M. Stefani (2002)
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 416
R. Bassel-Duby, E. Olson (2006)
Signaling pathways in skeletal muscle remodeling.Annual review of biochemistry, 75
Y. Kallberg, M. Gustafsson, B. Persson, J. Thyberg, Janne Johansson (2001)
Prediction of Amyloid Fibril-forming Proteins*The Journal of Biological Chemistry, 276
D. Walsh, D. Hartley, Y. Kusumoto, Y. Fezoui, M. Condron, A. Lomakin, G. Benedek, D. Selkoe, D. Teplow (1999)
Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.The Journal of biological chemistry, 274 36
M. Török, S. Milton, R. Kayed, Peng Wu, Theresa McIntire, C. Glabe, R. Langen (2002)
Structural and Dynamic Features of Alzheimer's Aβ Peptide in Amyloid Fibrils Studied by Site-directed Spin Labeling*The Journal of Biological Chemistry, 277
L. Morozova-Roche, V. Zamotin, M. Mališauskas, A. Ohman, R. Chertkova, M. Lavrikova, I. Kostanyan, D. Dolgikh, M. Kirpichnikov (2004)
Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways.Biochemistry, 43 30
Motomasa Tanaka, Peter Chien, K. Yonekura, J. Weissman (2005)
Mechanism of Cross-Species Prion Transmission An Infectious Conformation Compatible withTwo Highly Divergent Yeast Prion ProteinsCell, 121
M. Chapman, Lloyd Robinson, J. Pinkner, Robyn Roth, J. Heuser, M. Hammar, S. Normark, S. Hultgren (2002)
Role of Escherichia coli Curli Operons in Directing Amyloid Fiber FormationScience, 295
D. Moechars, I. Dewachter, K. Lorent, D. Reversé, V. Baekelandt, A. Naidu, I. Tesseur, K. Spittaels, C. Haute, F. Checler, E. Godaux, B. Cordell, F. Leuven (1999)
Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain*The Journal of Biological Chemistry, 274
B. Giasson, M. Forman, M. Higuchi, L. Golbe, C. Graves, P. Kotzbauer, J. Trojanowski, V. Lee (2003)
Initiation and Synergistic Fibrillization of Tau and Alpha-SynucleinScience, 300
V. Uversky, A. Fink (2004)
Conformational constraints for amyloid fibrillation: the importance of being unfolded.Biochimica et biophysica acta, 1698 2
M. Mališauskas, J. Ostman, A. Darinskas, V. Zamotin, E. Liutkevicius, E. Lundgren, L. Morozova-Roche (2005)
Does the Cytotoxic Effect of Transient Amyloid Oligomers from Common Equine Lysozyme in Vitro Imply Innate Amyloid Toxicity?*Journal of Biological Chemistry, 280
Claudia Parrini, N. Taddei, M. Ramazzotti, D. Degl’Innocenti, G. Ramponi, C. Dobson, F. Chiti (2005)
Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation.Structure, 13 8
Axelle Balguerie, Suzana Reis, C. Ritter, S. Chaignepain, Bénédicte Coulary-Salin, V. Forge, Katell Bathany, I. Lascu, J. Schmitter, R. Riek, S. Saupe (2003)
Domain organization and structure–function relationship of the HET‐s prion protein of Podospora anserinaThe EMBO Journal, 22
R. Krishnan, S. Lindquist (2005)
Structural insights into a yeast prion illuminate nucleation and strain diversityNature, 435
M. Podlisny, B. Ostaszewski, S. Squazzo, E. Koo, R. Rydell, D. Teplow, D. Selkoe (1995)
Aggregation of Secreted Amyloid -Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture (*)The Journal of Biological Chemistry, 270
W. Hoyer, D. Cherny, V. Subramaniam, T. Jovin (2004)
Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.Biochemistry, 43 51
B. Broome, M. Hecht (2000)
Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis.Journal of molecular biology, 296 4
Horst Bauer, Ueli Aebi, M. Häner, René Hermann, Martin Müller, Tudor Arvinte, Hans Merkle (1995)
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin.Journal of structural biology, 115 1
A. Alexandrescu (2005)
Amyloid accomplices and enforcersProtein Science, 14
J. Harper, Stanislaus Wong, Charles Lieber, P. Lansbury (1997)
Observation of metastable Aβ amyloid protofibrils by atomic force microscopyChemistry & Biology, 4
A. Quintas, Daniela Vaz, I. Cardoso, M. Saraiva, R. Brito (2001)
Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants*The Journal of Biological Chemistry, 276
J. Jimenez, J. Guijarro, E. Orlova, J. Zurdo, C. Dobson, M. Sunde, H. Saibil (1999)
Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packingThe EMBO Journal, 18
U. Baxa, N. Cheng, Dennis Winkler, T. Chiu, D. Davies, D. Sharma, H. Inouye, D. Kirschner, R. Wickner, A. Steven (2005)
Filaments of the Ure2p prion protein have a cross-β core structureJournal of Structural Biology, 150
M. Dumoulin, A. Last, A. Desmyter, K. Decanniere, D. Canet, G. Larsson, A. Spencer, D. Archer, J. Sasse, S. Muyldermans, L. Wyns, C. Redfield, A. Matagne, C. Robinson, C. Dobson (2003)
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozymeNature, 424
S. Petty, S. Decatur (2005)
Intersheet rearrangement of polypeptides during nucleation of β-sheet aggregatesProceedings of the National Academy of Sciences of the United States of America, 102
D. Canet, A. Last, P. Tito, M. Sunde, A. Spencer, D. Archer, C. Redfield, C. Robinson, C. Dobson (2002)
Local cooperativity in the unfolding of an amyloidogenic variant of human lysozymeNature Structural Biology, 9
Kateri Dubay, Amol Pawar, F. Chiti, J. Zurdo, C. Dobson, M. Vendruscolo (2004)
Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains.Journal of molecular biology, 341 5
Koichi Iijima, Hsin-Ping Liu, A. Chiang, Stephen Hearn, M. Konsolaki, Y. Zhong (2004)
Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's diseaseProceedings of the National Academy of Sciences of the United States of America, 101
G. Hirschfield, P. Hawkins (2003)
Amyloidosis: new strategies for treatment.The international journal of biochemistry & cell biology, 35 12
R. Raffen, L. Dieckman, Meredith Szpunar, Christine Wunschl, P. Pokkuluri, Poras Dave, P. Stevens, X. Cai, M. Schiffer, F. Stevens (2008)
Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chainsProtein Science, 8
Caroline Wright, S. Teichmann, J. Clarke, C. Dobson (2005)
The importance of sequence diversity in the aggregation and evolution of proteinsNature, 438
C. Bertoncini, Young-Sang Jung, Claudio Fernandez, Wolfgang Hoyer, Christian Griesinger, T. Jovin, M. Zweckstetter (2005)
Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein.Proceedings of the National Academy of Sciences of the United States of America, 102 5
J. Sacchettini, J. Kelly (2002)
Therapeutic strategies for human amyloid diseasesNature Reviews Drug Discovery, 1
J. Dodart, K. Bales, K. Gannon, S. Greene, R. DeMattos, C. Mathis, C. Delong, Su Wu, Xin Wu, D. Holtzman, S. Paul (2002)
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelNature Neuroscience, 5
R. Khurana, V. Uversky, L. Nielsen, A. Fink (2001)
Is Congo Red an Amyloid-specific Dye?*The Journal of Biological Chemistry, 276
T. Serio, A. Cashikar, A. Kowal, G. Sawicki, J. Moslehi, L. Serpell, M. Arnsdorf, S. Lindquist (2000)
Nucleated conformational conversion and the replication of conformational information by a prion determinant.Science, 289 5483
M. Fändrich, C. Dobson (2002)
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formationThe EMBO Journal, 21
G. Bitan, A. Lomakin, D. Teplow (2001)
Amyloid (cid:1) -Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS*
P. Westermark, M. Benson, J. Buxbaum, A. Cohen, B. Frangione, S. Ikeda, C. Masters, G. Merlini, M. Saraiva, J. Sipe (2005)
Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of AmyloidosisAmyloid, 12
F. Chiti, N. Taddei, M. Stefani, C. Dobson, G. Ramponi (2001)
Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformationProtein Science, 10
M. Stefani, C. Dobson (2003)
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 81
Kausik Si, S. Lindquist, E. Kandel (2003)
A Neuronal Isoform of the Aplysia CPEB Has Prion-Like PropertiesCell, 115
M. Sousa, I. Cardoso, R. Fernandes, A. Guimarães, M. Saraiva (2001)
Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.The American journal of pathology, 159 6
A. Bush (2003)
The metallobiology of Alzheimer's diseaseTrends in Neurosciences, 26
Qinghai Zhang, E. Powers, J. Nieva, Mary Huff, Maria Dendle, J. Bieschke, C. Glabe, A. Eschenmoser, P. Wentworth, R. Lerner, J. Kelly (2004)
Metabolite-initiated protein misfolding may trigger Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America, 101 14
M. Margittai, R. Langen (2004)
Template-assisted filament growth by parallel stacking of tau.Proceedings of the National Academy of Sciences of the United States of America, 101 28
G. Zandomeneghi, M. Krebs, Margaret McCammon, M. Fändrich (2004)
FTIR reveals structural differences between native β‐sheet proteins and amyloid fibrilsProtein Science, 13
V. Uversky, Jie Li, P. Souillac, I. Millett, S. Doniach, R. Jakes, M. Goedert, A. Fink (2002)
Biophysical Properties of the Synucleins and Their Propensities to FibrillateThe Journal of Biological Chemistry, 277
C. Pike, A. Walencewicz, C. Glabe, C. Cotman (1991)
In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicityBrain Research, 563
(2003)
Genes Dev
A. Petkova, Y. Ishii, J. Balbach, O. Antzutkin, R. Leapman, F. Delaglio, R. Tycko (2002)
A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.Proceedings of the National Academy of Sciences of the United States of America, 99 26
(2005)
D ow nl oa de d fr om a rj ou rn al s. an nu al re vi ew s. or g by C E N T R O I N V E ST IG A C IO N E S B IO L O G IC A S
A. Petkova, R. Leapman, Zhihong Guo, Wai‐Ming Yau, M. Mattson, R. Tycko (2005)
Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid FibrilsScience, 307
C. Dobson (1999)
Protein misfolding, evolution and disease.Trends in biochemical sciences, 24 9
Claudio Fernández, W. Hoyer, M. Zweckstetter, E. Jares-Erijman, V. Subramaniam, C. Griesinger, T. Jovin (2004)
NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregationThe EMBO Journal, 23
T. Konno (2001)
Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril.Biochemistry, 40 7
H. True, Ilana Berlin, S. Lindquist (2004)
Epigenetic regulation of translation reveals hidden genetic variation to produce complex traitsNature, 431
G. Bitan, M. Kirkitadze, A. Lomakin, Sabrina Vollers, G. Benedek, D. Teplow (2002)
Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathwaysProceedings of the National Academy of Sciences of the United States of America, 100
Georgia Plakoutsi, N. Taddei, M. Stefani, F. Chiti (2004)
Aggregation of the Acylphosphatase from Sulfolobus solfataricusJournal of Biological Chemistry, 279
F. Cohen, J. Kelly (2003)
Therapeutic approaches to protein-misfolding diseasesNature, 426
J. Silveira, G. Raymond, A. Hughson, R. Race, Valerie Sim, S. Hayes, B. Caughey (2005)
The most infectious prion protein particlesNature, 437
D. Masison, M. Maddelein, R. Wickner (1997)
The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation.Proceedings of the National Academy of Sciences of the United States of America, 94 23
Amol Pawar, Kateri Dubay, J. Zurdo, F. Chiti, M. Vendruscolo, C. Dobson (2005)
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.Journal of molecular biology, 350 2
I. Kheterpal, Shaolian Zhou, Kelsey Cook, Ronald Wetzel (2000)
Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange.Proceedings of the National Academy of Sciences of the United States of America, 97 25
C. Ritter, M. Maddelein, Ansgar Siemer, Thorsten Lührs, M. Ernst, B. Meier, S. Saupe, R. Riek (2005)
Correlation of structural elements and infectivity of the HET-s prionNature, 435
V. Iconomidou, G. Vriend, S. Hamodrakas (2000)
Amyloids protect the silkmoth oocyte and embryoFEBS Letters, 479
R. Kayed, Y. Sokolov, B. Edmonds, Theresa McIntire, S. Milton, James Hall, C. Glabe (2004)
Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases*Journal of Biological Chemistry, 279
(2001)
Proteins, Amyloid, and Disease 365 A nn u
C. Jaroniec, C. MacPhee, V. Bajaj, M. McMahon, C. Dobson, R. Griffin (2004)
High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy.Proceedings of the National Academy of Sciences of the United States of America, 101 3
L. Serpell, M. Sunde, M. Benson, G. Tennent, M. Pepys, P. Fraser (2000)
The protofilament substructure of amyloid fibrils.Journal of molecular biology, 300 5
Peter Chien, J. Weissman, A. DePace (2004)
Emerging principles of conformation-based prion inheritance.Annual review of biochemistry, 73
F. Chiti, N. Taddei, F. Baroni, C. Capanni, M. Stefani, G. Ramponi, C. Dobson (2002)
Kinetic partitioning of protein folding and aggregationNature Structural Biology, 9
Angela Williams, M. Sega, Maolian Chen, I. Kheterpal, M. Geva, V. Berthelier, David Kaleta, K. Cook, R. Wetzel (2005)
Structural properties of Abeta protofibrils stabilized by a small molecule.Proceedings of the National Academy of Sciences of the United States of America, 102 20
From DNA Polymerase to Viral Latency I
C. Jaroniec, C. MacPhee, Nathan Astrof, C. Dobson, R. Griffin (2002)
Molecular conformation of a peptide fragment of transthyretin in an amyloid fibrilProceedings of the National Academy of Sciences of the United States of America, 99
(2006)
Downloaded from arjournals.annualreviews.org by CENTRO INVESTIGACIONES BIOLOGICAS on 02/13/07. For personal use only
H. Gertz, Antje Siegers, J. Kuchinke (1994)
Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's diseaseBrain Research, 637
G. Calloni, Sara Zoffoli, M. Stefani, C. Dobson, F. Chiti (2005)
Investigating the Effects of Mutations on Protein Aggregation in the Cell*Journal of Biological Chemistry, 280
C. Mar, Eric Greenbaum, L. Mayne, S. Englander, Virgil Woods (2005)
Structure and properties of α-synuclein and other amyloids determined at the amino acid levelProceedings of the National Academy of Sciences of the United States of America, 102
H. Nguyen, C. Hall (2004)
Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides.Proceedings of the National Academy of Sciences of the United States of America, 101 46
Angela Williams, E. Portelius, I. Kheterpal, Jun-tao Guo, K. Cook, Ying Xu, R. Wetzel (2004)
Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis.Journal of molecular biology, 335 3
D. Crowther, K. Kinghorn, E. Miranda, Richard Page, J. Curry, F. Duthie, D. Gubb, D. Lomas (2005)
Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s diseaseNeuroscience, 132
H. Naiki, N. Hashimoto, S. Suzuki, H. Kimura, K. Nakakuki, F. Gejyo (1997)
Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitroAmyloid, 4
S. Jayasinghe, R. Langen (2004)
Identifying Structural Features of Fibrillar Islet Amyloid Polypeptide Using Site-directed Spin Labeling*Journal of Biological Chemistry, 279
E. Jones, W. Surewicz (2005)
Fibril Conformation as the Basis of Species- and Strain-Dependent Seeding Specificity of Mammalian Prion AmyloidsCell, 121
H. Miake, H. Mizusawa, T. Iwatsubo, M. Hasegawa (2002)
Biochemical Characterization of the Core Structure of α-Synuclein Filaments*The Journal of Biological Chemistry, 277
J. Pedersen, G. Christensen, D. Otzen (2004)
Modulation of S6 fibrillation by unfolding rates and gatekeeper residues.Journal of molecular biology, 341 2
M. Amaral (2007)
CFTR and chaperonesJournal of Molecular Neuroscience, 23
D. Claessen, R. Rink, W. Jong, Jeroen Siebring, Peter Vreugd, F. Boersma, L. Dijkhuizen, H. Wosten (2003)
A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils.Genes & development, 17 14
K. Lundmark, G. Westermark, A. Olsén, P. Westermark (2005)
Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanismProceedings of the National Academy of Sciences of the United States of America, 102
A. Kajava, U. Baxa, R. Wickner, A. Steven (2004)
A model for Ure2p prion filaments and other amyloids: the parallel superpleated beta-structure.Proceedings of the National Academy of Sciences of the United States of America, 101 21
J. Mackay, J. Matthews, Robert Winefield, L. Mackay, R. Haverkamp, M. Templeton (2001)
The hydrophobin EAS is largely unstructured in solution and functions by forming amyloid-like structures.Structure, 9 2
D. Hartley, D. Walsh, C. Ye, T. Diehl, Sara Vasquez, P. Vassilev, D. Teplow, D. Selkoe (1999)
Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical NeuronsThe Journal of Neuroscience, 19
Masatoshi Saiki, S. Honda, K. Kawasaki, Deshan Zhou, A. Kaito, T. Konakahara, H. Morii (2005)
Higher-order molecular packing in amyloid-like fibrils constructed with linear arrangements of hydrophobic and hydrogen-bonding side-chains.Journal of molecular biology, 348 4
V. Villegas, J. Zurdo, V. Filimonov, F. Avilés, C. Dobson, Luis Serrano (2000)
Protein engineering as a strategy to avoid formation of amyloid fibrilsProtein Science, 9
C. Bianco, J. Ridet, Bernard L. Schneider, N. Déglon, Patrick Aebischer (2002)
α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 99
M. Hoshino, H. Katou, Y. Hagihara, K. Hasegawa, H. Naiki, Y. Goto (2002)
Mapping the core of the β2-microglobulin amyloid fibril by H/D exchangeNature Structural Biology, 9
M. Mališauskas, V. Zamotin, J. Jass, W. Noppe, C. Dobson, L. Morozova-Roche (2003)
Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration.Journal of molecular biology, 330 4
Y. Fezoui, D. Teplow (2002)
Kinetic Studies of Amyloid β-Protein Fibril AssemblyThe Journal of Biological Chemistry, 277
M. Pepys (2001)
Pathogenesis, diagnosis and treatment of systemic amyloidosis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 356 1406
M. Monti, S. Principe, S. Giorgetti, P. Mangione, G. Merlini, A. Clark, V. Bellotti, A. Amoresano, P. Pucci (2002)
Topological investigation of amyloid fibrils obtained from β2‐microglobulinProtein Science, 11
M. Sunde, C. Blake (1997)
The structure of amyloid fibrils by electron microscopy and X-ray diffraction.Advances in protein chemistry, 50
A. Modler, K. Gast, G. Lutsch, Gregor Damaschun (2003)
Assembly of amyloid protofibrils via critical oligomers--a novel pathway of amyloid formation.Journal of molecular biology, 325 1
O. Antzutkin, J. Balbach, R. Leapman, N. Rizzo, J. Reed, R. Tycko (2000)
Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrilsProceedings of the National Academy of Sciences of the United States of America, 97
A. Roher, M. Chaney, Y. Kuo, S. Webster, W. Stine, L. Haverkamp, Amina Woods, R. Cotter, J. Tuohy, G. Krafft, B. Bonnell, M. Emmerling (1996)
Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease*The Journal of Biological Chemistry, 271
K. Lindorff-Larsen, R. Best, M. DePristo, C. Dobson, M. Vendruscolo (2005)
Simultaneous determination of protein structure and dynamicsNature, 433
Z. Ignatova, L. Gierasch (2004)
Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling.Proceedings of the National Academy of Sciences of the United States of America, 101 2
G. Giaever, A. Chu, L. Ni, C. Connelly, L. Riles, S. Véronneau, Sally Dow, A. Lucau-Danila, K. Anderson, B. André, A. Arkin, A. Astromoff, M. Bakkoury, R. Bangham, Rocio Benito, S. Brachat, S. Campanaro, M. Curtiss, K. Davis, A. Deutschbauer, K. Entian, Patrick Flaherty, F. Foury, D. Garfinkel, M. Gerstein, D. Gotte, U. Güldener, J. Hegemann, S. Hempel, Z. Herman, Daniel Jaramillo, D. Kelly, S. Kelly, P. Kötter, D. Labonte, D. Lamb, N. Lan, Hong Liang, Hong Liao, Lucy Liu, C. Luo, M. Lussier, Rong Mao, Patrice Ménard, S. Ooi, J. Revuelta, C. Roberts, M. Rose, P. Ross-Macdonald, B. Scherens, G. Schimmack, B. Shafer, D. Shoemaker, Sharon Sookhai-Mahadeo, R. Storms, J. Strathern, G. Valle, M. Voet, G. Volckaert, Ching-yun Wang, T. Ward, J. Wilhelmy, E. Winzeler, Yonghong Yang, Grace Yen, E. Youngman, Kexin Yu, H. Bussey, J. Boeke, M. Snyder, P. Philippsen, Ronald Davis, M. Johnston (2002)
Functional profiling of the Saccharomyces cerevisiae genomeNature, 418
C. Bergeron, C. Petrunka, L. Weyer (1996)
Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability.The American journal of pathology, 148 1
Luc Bousset, N. Thomson, S. Radford, R. Melki (2002)
The yeast prion Ure2p retains its native α‐helical conformation upon assembly into protein fibrils in vitroThe EMBO Journal, 21
T. Nakayashiki, C. Kurtzman, H. Edskes, R. Wickner (2005)
Yeast prions [URE3] and [PSI+] are diseases.Proceedings of the National Academy of Sciences of the United States of America, 102 30
J. Guijarro, M. Sunde, Jonathan Jones, I. Campbell, C. Dobson (1998)
Amyloid fibril formation by an SH3 domain.Proceedings of the National Academy of Sciences of the United States of America, 95 8
M. Perutz, J. Finch, J. Berriman, A. Lesk (2002)
Amyloid fibers are water-filled nanotubesProceedings of the National Academy of Sciences of the United States of America, 99
Cristian Ionescu-Zanetti, R. Khurana, J. Gillespie, Jay Petrick, Lynne Trabachino, Lauren Minert, Sue Carter, Anthony Fink (1999)
Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy.Proceedings of the National Academy of Sciences of the United States of America, 96 23
J. Harper, J. Harper, Charles Lieber, P. Lansbury (1997)
Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.Chemistry & biology, 4 12
(2004)
Biochemistry 44:4720–26 89b
J. Larson, G. Lynch, D. Games, P. Seubert (1999)
Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP miceBrain Research, 840
G. Tartaglia, A. Cavalli, R. Pellarin, A. Caflisch (2004)
The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation ratesProtein Science, 13
T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, M. Yokochi, Y. Mizuno, N. Shimizu (1998)
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismNature, 392
H. Heise, W. Hoyer, S. Becker, O. Andronesi, D. Riedel, M. Baldus (2005)
Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR.Proceedings of the National Academy of Sciences of the United States of America, 102 44
G. Merlini, P. Westermark (2004)
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapiesJournal of Internal Medicine, 255
Michelle Chow, A. Ellisdon, Lisa Cabrita, S. Bottomley (2004)
Polyglutamine Expansion in Ataxin-3 Does Not Affect Protein StabilityJournal of Biological Chemistry, 279
Catriona McLean, Catriona McLean, R. Cherny, R. Cherny, Fiona Fraser, Fiona Fraser, S. Fuller, S. Fuller, Margaret Smith, Konrad Vbeyreuther, A. Bush, A. Bush, A. Bush, C. Masters, Colin Masters (1999)
Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's diseaseAnnals of Neurology, 46
R. Schwartz, S. Istrail, J. King (2001)
Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residuesProtein Science, 10
P. Auluck, H. Chan, J. Trojanowski, V. Lee, N. Bonini (2001)
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's DiseaseScience, 295
Mario Bouchard, J. Zurdo, E. Nettleton, C. Dobson, C. Robinson (2000)
Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopyProtein Science, 9
J. Schmittschmitt, J. Scholtz (2003)
The role of protein stability, solubility, and net charge in amyloid fibril formationProtein Science, 12
V. Uversky (2002)
Natively unfolded proteins: A point where biology waits for physicsProtein Science, 11
J. Berson, Alexander Theos, D. Harper, D. Tenza, G. Raposo, M. Marks (2003)
Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesisThe Journal of Cell Biology, 161
H. True, S. Lindquist (2000)
A yeast prion provides a mechanism for genetic variation and phenotypic diversityNature, 407
K. Lundmark, G. Westermark, S. Nyström, C. Murphy, A. Solomon, P. Westermark (2002)
Transmissibility of systemic amyloidosis by a prion-like mechanismProceedings of the National Academy of Sciences of the United States of America, 99
Luc Bousset, F. Briki, J. Doucet, R. Melki (2003)
The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils.Journal of structural biology, 141 2
R. Nelson, M. Sawaya, M. Balbirnie, A. Madsen, C. Riekel, Robert Grothe, D. Eisenberg (2005)
Structure of the cross-β spine of amyloid-like fibrilsNature, 435
V. Uversky, A. Fink (2006)
Protein Misfolding, Aggregation, and Conformational Diseases
M. Krebs, C. MacPhee, A. Miller, I. Dunlop, C. Dobson, A. Donald (2004)
The formation of spherulites by amyloid fibrils of bovine insulin.Proceedings of the National Academy of Sciences of the United States of America, 101 40
M. Monti, Barbara Bard, G. Calloni, F. Chiti, A. Amoresano, Gianpietro Ramponi, P. Pucci (2004)
The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process.Journal of molecular biology, 336 1
J. Balbach, A. Petkova, N. Oyler, O. Antzutkin, D. Gordon, S. Meredith, R. Tycko (2002)
Supramolecular Structure in Full-Length Alzheimer's β-Amyloid Fibrils: Evidence for a Parallel β-Sheet Organization from Solid-State Nuclear Magnetic ResonanceBiophysical Journal, 83
F. Chiti, N. Taddei, M. Bucciantini, P. White, G. Ramponi, C. Dobson (2000)
Mutational analysis of the propensity for amyloid formation by a globular proteinThe EMBO Journal, 19
A. Fernández-Escamilla, F. Rousseau, J. Schymkowitz, L. Serrano (2004)
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteinsNature Biotechnology, 22
I. Sirangelo, C. Malmo, Clara Iannuzzi, A. Mezzogiorno, M. Bianco, M. Papa, G. Irace (2004)
Fibrillogenesis and Cytotoxic Activity of the Amyloid-forming Apomyoglobin Mutant W7FW14F*Journal of Biological Chemistry, 279
Daniel Otzen, Ole Kristensen, Mikael Oliveberg (2000)
Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly.Proceedings of the National Academy of Sciences of the United States of America, 97 18
N. Reixach, S. Deechongkit, Xin Jiang, J. Kelly, J. Buxbaum (2004)
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture.Proceedings of the National Academy of Sciences of the United States of America, 101 9
J. Kenney, D. Knight, M. Wise, F. Vollrath (2002)
Amyloidogenic nature of spider silk.European journal of biochemistry, 269 16
J. Jimenez, E. Nettleton, Mario Bouchard, C. Robinson, C. Dobson, H. Saibil (2002)
The protofilament structure of insulin amyloid fibrilsProceedings of the National Academy of Sciences of the United States of America, 99
R. Kayed, E. Head, J. Thompson, Theresa McIntire, S. Milton, C. Cotman, C. Glabe (2003)
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 300
Lee‐way Jin, K. Claborn, Miki Kurimoto, M. Geday, Izumi Maezawa, Faranak Sohraby, Marcus Estrada, Werner Kaminksy, B. Kahr (2003)
Imaging linear birefringence and dichroism in cerebral amyloid pathologiesProceedings of the National Academy of Sciences of the United States of America, 100
F. Chiti, Martino Calamai, N. Taddei, M. Stefani, G. Ramponi, C. Dobson (2002)
Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseasesProceedings of the National Academy of Sciences of the United States of America, 99
F. Chiti, M. Stefani, N. Taddei, G. Ramponi, C. Dobson (2003)
Rationalization of the effects of mutations on peptide andprotein aggregation ratesNature, 424
J. Kyte, R. Doolittle (1982)
A simple method for displaying the hydropathic character of a protein.Journal of molecular biology, 157 1
C. Nilsberth, A. Westlind‐Danielsson, C. Eckman, M. Condron, K. Axelman, C. Forsell, C. Stenh, J. Luthman, D. Teplow, S. Younkin, J. Näslund, L. Lannfelt (2001)
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 4
M. Krebs, L. Morozova-Roche, Katie Daniel, C. Robinson, C. Dobson (2004)
Observation of sequence specificity in the seeding of protein amyloid fibrilsProtein Science, 13
S. Paushkin, V. Kushnirov, V. Smirnov, M. Ter‐Avanesyan (1996)
Propagation of the yeast prion‐like [psi+] determinant is mediated by oligomerization of the SUP35‐encoded polypeptide chain release factor.The EMBO Journal, 15
Astria Ferrão-Gonzales, Sandro Souto, Jerson Silva, D. Foguel (2000)
The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state.Proceedings of the National Academy of Sciences of the United States of America, 97 12
Jeffery Kelly (1998)
The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways.Current opinion in structural biology, 8 1
S. Eaglestone, B. Cox, M. Tuite (1999)
Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion‐mediated mechanismThe EMBO Journal, 18
Annette Steward, S. Adhya, J. Clarke (2002)
Sequence conservation in Ig-like domains: the role of highly conserved proline residues in the fibronectin type III superfamily.Journal of molecular biology, 318 4
G. Legname, I. Baskakov, Hoang-Oanh Nguyen, D. Riesner, F. Cohen, S. DeArmond, S. Prusiner (2004)
Synthetic Mammalian PrionsScience, 305
N. Chayen (2005)
Methods for separating nucleation and growth in protein crystallisation.Progress in biophysics and molecular biology, 88 3
M. Nilsson (2004)
Techniques to study amyloid fibril formation in vitro.Methods, 34 1
A. Lorenzo, B. Yankner (1994)
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.Proceedings of the National Academy of Sciences of the United States of America, 91 25
S. Saupe (2000)
Molecular Genetics of Heterokaryon Incompatibility in Filamentous AscomycetesMicrobiology and Molecular Biology Reviews, 64
Melanie Nilsson, M. Driscoll, Daniel Raleigh (2000)
Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides : Implications for the study of amyloid formation
O. Makin, E. Atkins, P. Sikorski, J. Johansson, L. Serpell (2005)
Molecular basis for amyloid fibril formation and stability.Proceedings of the National Academy of Sciences of the United States of America, 102 2
D. Walsh, A. Lomakin, G. Benedek, M. Condron, D. Teplow (1997)
Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.The Journal of biological chemistry, 272 35
(2003)
Trends Neurosci
V. Coustou, C. Deleu, S. Saupe, J. Bégueret (1997)
The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog.Proceedings of the National Academy of Sciences of the United States of America, 94 18
J. Pedersen, D. Dikov, James Flink, H. Hjuler, G. Christiansen, D. Otzen (2006)
The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting.Journal of molecular biology, 355 3
D. Lomas, R. Carrell (2002)
Human genetics and disease: Serpinopathies and the conformational dementiasNature Reviews Genetics, 3
S. Ray, R. Nowak, Robert Brown, P. Lansbury (2005)
Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation.Proceedings of the National Academy of Sciences of the United States of America, 102 10
U. Baxa, K. Taylor, J. Wall, M. Simon, N. Cheng, R. Wickner, A. Steven (2003)
Architecture of Ure2p Prion FilamentsJournal of Biological Chemistry, 278
O. EI-Agnaf, G. Irvine (2001)
Aggregation and neurotoxicity of α-synuclein and related peptidesBiochemical Society Transactions, 30
K. Conway, and Harper, P. Lansbury (2000)
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.Biochemistry, 39 10
Abstract Peptides or proteins convert under some conditions from their soluble forms into highly ordered fibrillar aggregates. Such transitions can give rise to pathological conditions ranging from neurodegenerative disorders to systemic amyloidoses. In this review, we identify the diseases known to be associated with formation of fibrillar aggregates and the specific peptides and proteins involved in each case. We describe, in addition, that living organisms can take advantage of the inherent ability of proteins to form such structures to generate novel and diverse biological functions. We review recent advances toward the elucidation of the structures of amyloid fibrils and the mechanisms of their formation at a molecular level. Finally, we discuss the relative importance of the common main-chain and side-chain interactions in determining the propensities of proteins to aggregate and describe some of the evidence that the oligomeric fibril precursors are the primary origins of pathological behavior.
Annual Review of Biochemistry – Annual Reviews
Published: Jul 7, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.